Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS

Clinical trial NCT03202394 · COMPLETED

Trial details

NCT number: NCT03202394
Sponsor: BioMarck Pharmaceuticals, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome, Adult

Start date: 2017-08-05
Primary completion: 2020-03-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.